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Introduction
Recently, cholesterol-independent effects of HMG-CoA
reductase inhibitors (statins) have been clarified, such as
modulation of cell morphology and/or cell-substrate
attachment [1]. Some of these effects are suggested to be
mediated by intermediate compounds of the cholesterol
synthesis, i.e., the isoprenoids [2].
Here, we investigated the effect of HMG-CoA reductase
inhibitor and/or the related compounds of the cholesterol
synthesis pathway on collagen gel-contractility, cell mor-
phology, and/or cell-substrate attachment of hepatic stel-
late cells (HSCs), using myofibroblast-like stellate cell line
derived from a CCl4-induced cirrhotic rat liver.
Methods
Materials
Simvastatin [3] was kindly provided by Merck & Co., Inc.
(Rahway, NJ) and was converted to open acid form before
use. Farnesylpyrophosphate (FPP) and geranylgeranyl-
pyrophosphate (GGPP) were obtained from Sigma
Chemical Co. (St. Louis, MO). Prenyltransferase inhibi-
tors; FTI-277, and GGTI-286, were from Calbiochem (La
Jolla, CA). A monoclonal antibody against phosphor-
ylated serine 19 of myosin regulatory light chain (anti-
MLC-pS19) was previously described [4]. A monoclonal
antibody against RhoA was from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA). Other materials were purchased
commercially.
Cell culture
The hepatic myofibroblast-like stellate cell line, CFSC-8B
(CFSC), derived from a CCl4-induced cirrhotic rat liver
[5], was maintained in DMEM and was supplemented
with 10% fatal calf serum (FCS).
Collagen gel-contraction assay
Contractility of CFSCs was evaluated using collagen gel
lattices on 24-well culture plates as described previously
[4].
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F-actin staining
For visualization of F-actin, the cells were stained over-
night with TRITC-labeled phalloidin (Sigma), and then
they were observed by fluorescence microscopy.
Cell adhesion assays
Cell adhesion was measured using the electric cell-sub-
strate impedance sensor system (ECIS; Applied BioPhys-
ics, Inc., Troy, NY) as described previously [4].
Immunoblotting
Cellular proteins were separated by SDS-PAGE, and
immunoblotted using anti-MLC-pS19 or anti-RhoA.
Immunoreactive proteins were visualized using a chemi-
luminescence kit (Amersham).
Statistical analysis
Data were given as the mean value with the standard error
of it, and were analyzed by the paired Student's t test.
Results and Discussion
HMG-CoA reductase inhibitors are widely used in
patients with liver disease, such as fatty liver and/or pri-
mary liver cirrhosis, however, the effects and the mecha-
nisms of these inhibitors on the liver remain uncertain as
well in HSCs [6,7]. They block the conversion of HMG-
CoA to mevalonate, the rate-limiting step in the synthesis
of cholesterol, moreover, several recent studies have been
focused on their cholesterol-independent effects. By mod-
ulating the initial part of the cholesterol synthesis path-
way, they decrease the level of numerous important
intermediate compounds including isoprenoids includ-
ing FPP and GGPP (Figure 1). Isoprenoids are lipid attach-
ments involved in post-translational modification of
some proteins such as gamma-subunit of the heterot-
rimeric G proteins, the small G proteins as Ras, Rho, Rap,
Rab, or Ral [2]. Thus, they can modulate various biologi-
cal or physiological mechanisms.
In the present study we found that the addition of 10-5M
of simvastatin attenuated the contractile activity of colla-
gen-gel by CFSCs, which was recovered by co-addition of
10-3M of mevalonate, the direct metabolite of HMG-CoA.
The inhibitory effect of simvastatin was also cancelled by
co-addition of 10-5M of GGPP, but not by 10-5M of FPP or
squalene, the late step product of the cholesterol synthe-
sis. Moreover, the inhibitory effect was partially repro-
duced by addition of 10-5M of GGTI, not by 10-5M of FTI.
Next, we found that cell morphology and/or the
formation of stress fibers of CFSCs by F-actin staining
were abrogated by simvastatin, which were maintained in
the presence of mevalonate, and GGPP, but not of FPP.
They were also attenuated in the presence of GGTI. We
revealed further that the adhesive area of CFSCs to extra-
cellular substrate by ECIS were reduced by simvastatin
and GGTI, which were maintained in the presence of
mevalonate, and GGPP. The above observations may sug-
gest that HMG-CoA inhibitor modulates the morphologi-
cal and cytoskeletal changes through the dynamic
reorganization of actin filaments, and the cell-extracellu-
lar matrix interaction, resulting in the attenuation of the
contraction of collagen gel lattices, and that protein gera-
nylgeranylation is involved in this mechanism. Protein
prenylation of RhoA is required to functional activities of
RhoA [2]. Western blotting analyses showed that phos-
phorylated myosin regulatory light chain and prenylated
RhoA were maintained in the presence of mevalonate,
and GGPP, which were attenuated in the presence of sim-
vastatin and/or GGTI. It may be suggested that prenylated
RhoA might be associated with collagen-gel contractility,
cell morphology, and/or cell-substrate attachment of
CFSCs exerted by simvastatin and/or the isoprenoids.
In conclusion, HMG-CoA reductase inhibitor may modu-
late CFSC morphology, its attachment to surrounding
extracellular matrix and its contraction by a mechanism
involving protein geranylgeranylation.
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